Drugs / KQB548
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07207707 | Sep 2025 → Sep 2026 overdue | — | Kumquat Biosciences Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KQB548 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07207707 ↗ |
| Route | Oral | “Oral KQB548” NCT07207707 ↗ |